KRAS and lung adenocarcinoma: As anticipated, in the KRAS and BRAF contexts where the TMB is generally high there was a poor correlation between co-mutation frequency in human lung adenocarcinoma and causal mouse effects, suggesting that in these subgroups, human mutational frequency does not predict the importance of most tumor suppressor genes (Supplementary Fig. 11A, B).